Federal officials have approved the start of human embryonic stem cell treatment experiments on patients suffering a leading cause of vision loss.
TIME: FDA Approves Second Trial of Stem-Cell Therapy
Tuesday, November 23rd, 2010For only the second time, the Food and Drug Administration approved a company’s request to test an embryonic stem cell-based therapy on human patients.
Reuters: Second U.S. Company Gets Stem Cell Go-Ahead
Tuesday, November 23rd, 2010The U.S. Food and Drug Administration has approved the second human trial of human embryonic stem cells — this one testing cells in people with a progressive form of blindness.
BBC: Human Trials to Start for Stem Cell Treatment for Blindness
Tuesday, November 23rd, 2010An American biotech company has just announced that it has been licensed to begin human trials of a stem cell treatment for blindness.
Washington Post: New Embryonic Stem Cell Experiment
Tuesday, November 23rd, 2010Government regulators have given the go-ahead to a second study that will for the first time carefully test a treatment created using human embryonic stem cells in people, according to the company sponsoring the experiment.
USA Today: Second human embryonic stem cell clinical trial to start
Tuesday, November 23rd, 2010Federal officials have cleared a second clinical trial of a human embryonic stem-cell treatment, a company announced Monday, for a progressive blindness syndrome affecting young people.
Associated Press: Feds OK 2nd Human Study of Embryonic Stem Cells
Tuesday, November 23rd, 2010NEW YORK (AP) – For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells – this time for a rare disease that causes serious vision loss.
New York Times: 2 Treatments for Retinas Make Gains
Tuesday, November 23rd, 2010Advanced Cell Technology, of Marlborough, Mass., said it would test its stem cell therapy on 12 adults with severe vision loss caused by Stargardt’s, an inherited disease. The company has turned human embryonic stem cells into retinal pigment epithelial cells, which will be surgically implanted into the eye. The hope is that the implanted cells […]